GLP-1 Agonist in Middle-Aged Obesity Versus Standard Diet and Exercise Effects on BP and HR

Four research articles were reviewed: three quantitative and one qualitative study. The goal was to evaluate the potential risks of using GLP-1 receptor agonists (GLP-1 RAs) to lower blood pressure and heart rate and promote weight loss in middle-aged obese adults compared to a standard diet and exercise regimen. The findings reveal a positive correlation between GLP-1 receptor agonists and weight loss and blood pressure reductions. However, further research is necessary to investigate any long-term complications related to the increased heart rate associated with GLP-1 RAs.

Files

Metadata

Work Title GLP-1 Agonist in Middle-Aged Obesity Versus Standard Diet and Exercise Effects on BP and HR
Access
Open Access
Creators
  1. John Troy Rubeck
Keyword
  1. Penn State Mont Alto Academic Festival 2025
  2. Undergraduate Research
License CC BY 4.0 (Attribution)
Work Type Poster
Acknowledgments
  1. Faculty Mentor: Alison Hawk
Publication Date April 25, 2025
Related URLs
  1. https://montalto.psu.edu/academics/festival
Deposited April 18, 2025

Versions

Analytics

Collections

Work History

Version 1
published

  • Created

    April 18, 2025 09:54 by tlr15

  • Updated

    April 18, 2025 09:54 by [unknown user]

  • Updated Keyword, Related URLs, Description, and 1 more Show Changes

    April 18, 2025 09:54 by tlr15

    Keyword
    • Penn State Mont Alto Academic Festival 2025, Undergraduate Research
    Related URLs
    • https://montalto.psu.edu/academics/festival
    Description
    • Four research articles were reviewed: three quantitative and one qualitative study. The goal was to evaluate the potential risks of using GLP-1 receptor agonists (GLP-1 RAs) to lower blood pressure and heart rate and promote weight loss in middle-aged obese adults compared to a standard diet and exercise regimen. The findings reveal a positive correlation between GLP-1 receptor agonists and weight loss and blood pressure reductions. However, further research is necessary to investigate any long-term complications related to the increased heart rate associated with GLP-1 RAs.
    Publication Date
    • 2025-04-25
  • Updated Acknowledgments Show Changes

    April 18, 2025 09:54 by tlr15

    Acknowledgments
    • Faculty Mentor: Alison Hawk
  • Added Creator John Troy Rubeck

    April 18, 2025 09:54 by tlr15

  • Added 58 GLP1 Agonist.pdf

    April 18, 2025 09:55 by tlr15

  • Updated License Show Changes

    April 18, 2025 09:55 by tlr15

    License
    • https://creativecommons.org/licenses/by/4.0/
  • Published

    April 18, 2025 09:55 by tlr15

  • Updated

    April 18, 2025 22:05 by [unknown user]